Clinical outcomes of early-stage triple-negative breast cancer after neoadjuvant chemotherapy according to HER2-low status☆.
Raghavendra AS, Zakon DB, Jin Q, Strahan A, Grimm M, Hughes ME, Cherian M, Vincuilla J, Parker T, Tarantino P, Mittendorf EA, King TA, Valero V, Tripathy D, Tolaney SM, Tayob N, Lin NU, Stover DG, Barcenas CH, Garrido-Castro AC.
Raghavendra AS, et al. Among authors: hughes me.
ESMO Open. 2024 Nov 4;9(11):103973. doi: 10.1016/j.esmoop.2024.103973. Online ahead of print.
ESMO Open. 2024.
PMID: 39500139
Free article.